ArticleOncotarget2017

Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma.

Javier Puente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.